|
FR2505657A1
(fr)
|
1981-05-13 |
1982-11-19 |
Pasteur Institut |
Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
|
|
US5626851A
(en)
|
1987-11-30 |
1997-05-06 |
The Wistar Institute Of Anatomy And Biology |
Rotavirus reassortant vaccine
|
|
US5096885A
(en)
|
1988-04-15 |
1992-03-17 |
Genentech, Inc. |
Human growth hormone formulation
|
|
ES2097120T3
(es)
|
1989-07-24 |
1997-04-01 |
Bayer Ag |
Estabilizacion de proteinas altamente purificadas.
|
|
WO1993018790A1
(en)
|
1992-03-24 |
1993-09-30 |
Csatary Laszlo K |
Vaccine containing live virus for therapy of viral diseases and malignancies
|
|
CA2075521C
(en)
|
1992-05-05 |
1995-11-28 |
Kuniaki Koyama |
Stabilized live vaccine
|
|
AU7971194A
(en)
|
1993-10-12 |
1995-05-04 |
Chiron Corporation |
Methods for preserving recombinant viruses
|
|
PL183781B1
(pl)
|
1994-05-16 |
2002-07-31 |
Merck & Co Inc |
Sposób wytwarzania szczepionki przeciwko ludzkiemu wirusowi brodawczaków
|
|
WO1996001651A1
(en)
|
1994-07-11 |
1996-01-25 |
The Government Of The United States Of America, Represented By The Department Of Health And Human Services |
Attenuated human rotavirus vaccine
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
PT2275119E
(pt)
|
1995-07-27 |
2013-11-21 |
Genentech Inc |
Formulação de proteína liofilizada isotónica estável
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US6165773A
(en)
|
1995-10-25 |
2000-12-26 |
Provalis Uk Limited |
Methods of preserving viruses
|
|
GB9521806D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Preservation methods
|
|
FR2742756B1
(fr)
|
1995-12-22 |
1998-04-03 |
Pasteur Merieux Serums Vacc |
Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
|
|
FR2751343B1
(fr)
|
1996-07-16 |
1998-12-18 |
Transgene Sa |
Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
|
|
US6403098B1
(en)
|
1996-09-26 |
2002-06-11 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US6616931B1
(en)
|
1996-09-26 |
2003-09-09 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
JP4653262B2
(ja)
|
1996-09-26 |
2011-03-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ロタウイルスワクチン製剤類
|
|
US5932223A
(en)
*
|
1996-09-26 |
1999-08-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
US20080261289A1
(en)
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
CA2274755A1
(en)
|
1996-12-20 |
1998-07-02 |
Su-Pi Sheu |
Stabilizers for lyophilized vaccines
|
|
US6051238A
(en)
|
1996-12-20 |
2000-04-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized mumps vaccines
|
|
US6290967B1
(en)
|
1996-12-20 |
2001-09-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized vaccines
|
|
US6565831B1
(en)
*
|
1999-02-24 |
2003-05-20 |
Oncolytics Biotech Inc. |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
|
|
JP4358434B2
(ja)
*
|
1998-02-17 |
2009-11-04 |
シェーリング コーポレイション |
ウイルスを含む組成物、およびウイルス調製物を濃縮するための方法
|
|
GB9808922D0
(en)
|
1998-04-24 |
1998-06-24 |
Cantab Pharmaceuticals Res Ltd |
Virus preparations
|
|
BRPI9912485B8
(pt)
|
1998-07-28 |
2021-05-25 |
The Government Of The Us Secretary Department Of Health And Human Services |
composição imunogênica multivalente
|
|
CN1062770C
(zh)
*
|
1998-11-12 |
2001-03-07 |
卫生部长春生物制品研究所 |
甲肝-麻疹二联疫苗及其生产方法
|
|
US6689600B1
(en)
*
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
DK1133316T3
(da)
|
1998-11-16 |
2009-05-25 |
Introgen Therapeutics Inc |
Adenovirus-formulering til genterapi
|
|
US6225289B1
(en)
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
JP4932086B2
(ja)
|
1999-04-08 |
2012-05-16 |
インターセル ユーエスエイ、インコーポレイテッド |
経皮的免疫のための乾燥製剤
|
|
US6592869B2
(en)
|
1999-08-24 |
2003-07-15 |
Teva Pharmaceutical Industries, Ltd. |
Vaccine composition and method of using the same
|
|
DK1212045T3
(en)
|
1999-08-24 |
2016-11-28 |
Abic Biological Laboratories Ltd |
VACCINE COMPOSITION AND METHOD OF USING IT
|
|
CN1188111C
(zh)
|
1999-10-29 |
2005-02-09 |
耐科塔医药公司 |
分散性得到改进的干粉组合物
|
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
EP1263461A4
(en)
|
2000-03-07 |
2009-08-12 |
Merck & Co Inc |
ADENOVIRUS FORMULATIONS
|
|
NZ552576A
(en)
|
2000-06-08 |
2008-06-30 |
Powderject Vaccines Inc |
Salt adjuvant-containing gel-forming free flowing compositions in a powder form for transdermal delivery from a needless syringe
|
|
US20020120228A1
(en)
|
2000-06-08 |
2002-08-29 |
Yuh-Fun Maa |
Powder compositions
|
|
US6689353B1
(en)
*
|
2000-06-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Stabilized interleukin 2
|
|
TWI289158B
(en)
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
GB0020089D0
(en)
|
2000-08-15 |
2000-10-04 |
Smithkline Beecham Biolog |
Vaccine Composition
|
|
JP5063852B2
(ja)
|
2000-09-25 |
2012-10-31 |
ポリマン サイエンティフィック イミューンバイオロジッシュ フォーシュング ゲゼルシャフト ミット ベシュレンクテル ファフツング |
生ワクチン及び製造方法
|
|
US20040033239A1
(en)
|
2001-03-06 |
2004-02-19 |
Evans Robert K |
Adenovirus formulations
|
|
MXPA03007535A
(es)
|
2001-03-16 |
2003-12-11 |
Oncolytics Biotech Inc |
Metodo para extraer virus de cultivo celular.
|
|
WO2002101412A2
(en)
|
2001-06-08 |
2002-12-19 |
Powderject Vaccines, Inc. |
Spray freeze-dried compositions
|
|
GB0124710D0
(en)
|
2001-10-15 |
2001-12-05 |
Quadrant Healthcare Uk Ltd |
Therapeutic composition
|
|
CN1287770C
(zh)
|
2001-11-19 |
2006-12-06 |
贝克顿迪肯森公司 |
颗粒型的药物组合物
|
|
JP2005517394A
(ja)
|
2001-12-12 |
2005-06-16 |
エフ エイチ フォールディング アンド カンパニー リミテッド |
ウイルス保存のための組成物
|
|
US20030153065A1
(en)
|
2002-01-14 |
2003-08-14 |
Genvec, Inc. |
Composition and method for maintaining non-enveloped viral vectors
|
|
EP1465664A1
(en)
|
2002-01-18 |
2004-10-13 |
Schering Aktiengesellschaft |
Stabilized formulations of adenovirus
|
|
AU2003234090A1
(en)
|
2002-04-11 |
2003-10-27 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for pulmonary administration
|
|
US7135180B2
(en)
|
2002-04-11 |
2006-11-14 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by freeze dried foam
|
|
WO2003086443A1
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
|
BR0309659A
(pt)
|
2002-04-30 |
2005-02-22 |
Oncolytics Biotech Inc |
Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
|
|
ATE352316T1
(de)
|
2002-11-01 |
2007-02-15 |
Glaxosmithkline Biolog Sa |
Immunogene zusammensetzung
|
|
US6752740B2
(en)
|
2002-11-12 |
2004-06-22 |
Jeffery T. Semmes |
Continuously variable transmission
|
|
KR20100107083A
(ko)
|
2002-12-17 |
2010-10-04 |
메디뮨 엘엘씨 |
생물활성 물질의 고압 분무 건조
|
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
|
NZ543467A
(en)
|
2003-04-10 |
2008-07-31 |
Novartis Vaccines & Diagnostic |
The severe acute respiratory syndrome coronavirus
|
|
NZ545639A
(en)
|
2003-09-02 |
2009-04-30 |
Glaxosmithkline Biolog Sa |
Cross-protective live attenuated human rotavirus vaccine
|
|
US20070148765A1
(en)
|
2003-11-19 |
2007-06-28 |
Evans Robert K |
Preservative-containing virus formulations
|
|
CA2549197C
(en)
|
2003-12-17 |
2015-04-14 |
Wyeth |
Methods for producing storage stable viruses and immunogenic compositions thereof
|
|
WO2005066333A1
(en)
|
2003-12-30 |
2005-07-21 |
Aventis Pasteur, Inc. |
Stabilizing compositions for recombinant viruses
|
|
GB0404586D0
(en)
|
2004-03-01 |
2004-04-07 |
Britannia Pharmaceuticals Ltd |
Improvements in or relating to organic materials
|
|
JP2007526329A
(ja)
|
2004-03-04 |
2007-09-13 |
ワイス |
賦形剤の結晶化を改善するための凍結乾燥法
|
|
ES2644416T3
(es)
|
2004-06-02 |
2017-11-28 |
Universal Stabilization Technologies, Inc. |
Conservación mediante vaporización
|
|
WO2006029467A1
(en)
|
2004-09-16 |
2006-03-23 |
Btf Pty Ltd |
Rapid freeze drying process
|
|
CA2579471A1
(en)
|
2004-09-28 |
2006-04-06 |
Alza Corporation |
Stabilization of alum-adjuvanted immunologically active agents
|
|
CA2583698C
(en)
*
|
2004-10-06 |
2014-12-02 |
Medimmune Vaccines, Inc. |
Refrigerator-temperature stable influenza vaccine compositions
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
CA2584815C
(en)
*
|
2004-11-05 |
2014-03-25 |
Wellstat Biologics Corporation |
Stable and filterable enveloped virus formulations
|
|
DE602005009402D1
(de)
|
2004-12-09 |
2008-10-09 |
Precimed Sa |
Operationsinstrumentenhalter für leichtere sterilisation
|
|
US20060141483A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Calton Gary J |
Stabilization of viral compositions
|
|
KR20070114753A
(ko)
*
|
2005-02-18 |
2007-12-04 |
아브락시스 바이오사이언스 인크. |
치료제의 조합 및 투여 방식, 및 조합 요법
|
|
HRP20110803T1
(hr)
*
|
2005-09-16 |
2011-11-30 |
Merial Ltd. |
Stabilizatori za cjepiva osušena zamrzavanjem
|
|
CN1765181A
(zh)
*
|
2005-10-19 |
2006-05-03 |
路兴波 |
高效抗病毒制剂
|
|
AU2007240797B2
(en)
|
2006-04-20 |
2013-05-23 |
Wyeth Llc |
Purification processes for isolating purified vesicular stomatitis virus from cell culture
|
|
JO3324B1
(ar)
|
2006-04-21 |
2019-03-13 |
Amgen Inc |
مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
|
|
EP1854478A1
(en)
|
2006-05-12 |
2007-11-14 |
Cytos Biotechnology AG |
Nicotine-carrier vaccine formulation
|
|
EP1878791A1
(en)
|
2006-07-11 |
2008-01-16 |
Bia Separations D.O.O. |
Method for influenza virus purification
|
|
WO2008018411A1
(en)
|
2006-08-07 |
2008-02-14 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Method for production of live smallpox vaccine
|
|
WO2008039761A2
(en)
|
2006-09-25 |
2008-04-03 |
Medimmune, Llc. |
Stabilized antibody formulations and uses thereof
|
|
DK2099485T3
(en)
|
2006-11-03 |
2018-05-22 |
Alphavax Inc |
Alphavirus and alphavirus replica particle formulations and associated methods
|
|
EP2086581B1
(en)
*
|
2006-11-07 |
2014-08-13 |
Sanofi Pasteur Biologics, LLC |
Stabilization of vaccines by lyophilization
|
|
ES2951660T3
(es)
*
|
2006-12-27 |
2023-10-24 |
Zoetis Services Llc |
Procedimientos de administración de vacunas
|
|
WO2008106646A2
(en)
|
2007-03-01 |
2008-09-04 |
Introgen Therapeutics, Inc |
Methods and formulations for topical gene therapy
|
|
ES2548442T3
(es)
*
|
2007-03-12 |
2015-10-16 |
Oncolytics Biotech Inc. |
Reovirus que tienen secuencias modificadas
|
|
GB0705245D0
(en)
|
2007-03-19 |
2007-04-25 |
Stabilitech Ltd |
Stable biological products
|
|
EP2829282B1
(en)
|
2007-03-22 |
2017-10-25 |
The Regents of The University of Colorado, A Body Corporate |
Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
|
|
DK2144998T3
(en)
|
2007-04-06 |
2017-04-10 |
Takeda Vaccines Inc |
Methods and compositions for live attenuated viruses
|
|
TW200909581A
(en)
|
2007-05-21 |
2009-03-01 |
Oncolytics Biotech Inc |
Mutant reoviruses and methods of making and using
|
|
US8241886B2
(en)
*
|
2007-09-25 |
2012-08-14 |
Aridis Pharmaceuticals |
Formulations for preservation of rotavirus
|
|
EP2394657A1
(en)
*
|
2007-10-12 |
2011-12-14 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
WO2009056651A1
(en)
|
2007-11-02 |
2009-05-07 |
Cytos Biotechnology Ag |
Angiotensin-carrier formulation
|
|
US8057796B2
(en)
|
2007-11-12 |
2011-11-15 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
US8227577B2
(en)
|
2007-12-21 |
2012-07-24 |
Hoffman-La Roche Inc. |
Bivalent, bispecific antibodies
|
|
MX2010009351A
(es)
|
2008-02-25 |
2011-03-04 |
Novavax Inc |
Particulas similares a virus cristalizadas con azucar.
|
|
WO2009133413A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Novatech D.O.O. |
Formulation based on micronized clinoptilolite as a therapeutic agent for removal of toxins, bacteria and viruses from organism
|
|
EP2805731B1
(en)
*
|
2009-09-03 |
2018-10-31 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
CA2819246C
(en)
|
2010-12-02 |
2023-04-25 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
|
CN103269716B
(zh)
*
|
2010-12-02 |
2015-05-27 |
昂科利蒂克斯生物科技公司 |
冻干病毒制剂
|
|
TW201307561A
(zh)
*
|
2011-04-29 |
2013-02-16 |
腫瘤防治生化科技公司 |
使用凝膠滲透層析法純化病毒之方法
|
|
JP6065096B2
(ja)
|
2015-12-25 |
2017-01-25 |
ダイキン工業株式会社 |
調湿装置
|